Igor Danelisen

1.2k total citations
16 papers, 979 citations indexed

About

Igor Danelisen is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Biophysics. According to data from OpenAlex, Igor Danelisen has authored 16 papers receiving a total of 979 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 6 papers in Molecular Biology and 5 papers in Biophysics. Recurrent topics in Igor Danelisen's work include Chemotherapy-induced cardiotoxicity and mitigation (10 papers), Electron Spin Resonance Studies (5 papers) and Cancer Treatment and Pharmacology (2 papers). Igor Danelisen is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (10 papers), Electron Spin Resonance Studies (5 papers) and Cancer Treatment and Pharmacology (2 papers). Igor Danelisen collaborates with scholars based in Canada, United States and China. Igor Danelisen's co-authors include Pawan K. Singal, Timao Li, Dinender Kumar, Natasha Iliskovic, Lorrie A. Kirshenbaum, Huiquan Lou, Hong Zhu, Zhenquan Jia, Y. Robert Li and Michael A. Trush and has published in prestigious journals such as Annals of the New York Academy of Sciences, Antioxidants and Redox Signaling and American Journal of Physiology-Heart and Circulatory Physiology.

In The Last Decade

Igor Danelisen

16 papers receiving 950 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Igor Danelisen Canada 12 583 383 224 149 141 16 979
Timao Li Canada 13 819 1.4× 452 1.2× 294 1.3× 206 1.4× 204 1.4× 17 1.3k
Liang Shao China 16 458 0.8× 438 1.1× 171 0.8× 74 0.5× 104 0.7× 48 1.1k
Dinender Kumar Canada 16 829 1.4× 722 1.9× 251 1.1× 148 1.0× 309 2.2× 22 1.7k
Zhang Ping China 15 403 0.7× 387 1.0× 170 0.8× 72 0.5× 97 0.7× 31 974
Lang Hong China 14 450 0.8× 378 1.0× 164 0.7× 68 0.5× 78 0.6× 35 939
Can Hu China 18 603 1.0× 814 2.1× 204 0.9× 88 0.6× 89 0.6× 31 1.6k
Ana Burgeiro Portugal 12 352 0.6× 326 0.9× 184 0.8× 70 0.5× 67 0.5× 16 945
Xinyong Cai China 14 403 0.7× 423 1.1× 153 0.7× 62 0.4× 77 0.5× 35 960
Olga Popelová Czechia 17 1.0k 1.7× 396 1.0× 455 2.0× 189 1.3× 248 1.8× 25 1.6k
Y Mazurová Czechia 18 489 0.8× 162 0.4× 181 0.8× 71 0.5× 146 1.0× 48 789

Countries citing papers authored by Igor Danelisen

Since Specialization
Citations

This map shows the geographic impact of Igor Danelisen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Danelisen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Danelisen more than expected).

Fields of papers citing papers by Igor Danelisen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor Danelisen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Danelisen. The network helps show where Igor Danelisen may publish in the future.

Co-authorship network of co-authors of Igor Danelisen

This figure shows the co-authorship network connecting the top 25 collaborators of Igor Danelisen. A scholar is included among the top collaborators of Igor Danelisen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igor Danelisen. Igor Danelisen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Zhu, Hong, et al.. (2023). Molecular mechanisms of action of metformin: latest advances and therapeutic implications. Clinical and Experimental Medicine. 23(7). 2941–2951. 24 indexed citations
2.
Li, Y. Robert, Hong Zhu, & Igor Danelisen. (2020). Role of Peroxiredoxins in Protecting Against Cardiovascular and Related Disorders. Cardiovascular Toxicology. 20(5). 448–453. 19 indexed citations
3.
Danelisen, Igor, et al.. (2018). Management of gastroesophageal reflux disease: Patient and physician communication challenges and shared decision making. World Journal of Clinical Cases. 6(15). 892–900. 15 indexed citations
5.
Zhu, Hong, Laura J. Scott, Igor Danelisen, et al.. (2016). Doxorubicin Redox Biology: Redox Cycling, Topoisomerase Inhibition, and Oxidative Stress. PubMed. 1(3). 189–198. 93 indexed citations
6.
Zhu, Hong, et al.. (2014). Paraoxonases function as unique protectors against cardiovascular diseases and diabetes: Updated experimental and clinical data. Experimental Biology and Medicine. 239(8). 899–906. 7 indexed citations
7.
Lou, Huiquan, Igor Danelisen, & Pawan K. Singal. (2005). Involvement of mitogen-activated protein kinases in adriamycin-induced cardiomyopathy. American Journal of Physiology-Heart and Circulatory Physiology. 288(4). H1925–H1930. 103 indexed citations
8.
Danelisen, Igor, Vince Palace, Huiquan Lou, & Pawan K. Singal. (2002). Maintenance of Myocardial Levels of Vitamin A in Heart Failure due to Adriamycin. Journal of Molecular and Cellular Cardiology. 34(7). 789–795. 14 indexed citations
9.
Li, Timao, Igor Danelisen, & Pawan K. Singal. (2002). Early changes in myocardial antioxidant enzymes in rats treated with adriamycin. Molecular and Cellular Biochemistry. 232(1-2). 19–26. 62 indexed citations
10.
Kumar, Dinender, Lorrie A. Kirshenbaum, Timao Li, Igor Danelisen, & Pawan K. Singal. (2001). Apoptosis in Adriamycin Cardiomyopathy and Its Modulation by Probucol. Antioxidants and Redox Signaling. 3(1). 135–145. 138 indexed citations
11.
Li, Timao, Igor Danelisen, Huiquan Lou, & Pawan K. Singal. (2001). Early changes in myocardial antioxidant enzymes in rats treated with adriamycin. Journal of Molecular and Cellular Cardiology. 33(6). A68–A68. 8 indexed citations
12.
Kumar, Dinender, Vince Palace, Igor Danelisen, Bodh I. Jugdutt, & Pawan K. Singal. (2001). Probucol induced antioxidants confers protection against I-R injury. Journal of Molecular and Cellular Cardiology. 33(6). A62–A62. 1 indexed citations
13.
Singal, Pawan K., Timao Li, Dinender Kumar, Igor Danelisen, & Natasha Iliskovic. (2000). Adriamycin-induced heart failure: mechanisms and modulation. Molecular and Cellular Biochemistry. 207(1-2). 77–86. 362 indexed citations
14.
Kumar, Dinender, Lorrie A. Kirshenbaum, Timao Li, Igor Danelisen, & Pawan K. Singal. (1999). Apoptosis in Isolated Adult Cardiomyocytes Exposed to Adriamycina. Annals of the New York Academy of Sciences. 874(1). 156–168. 79 indexed citations
15.
Iliskovic, Natasha, Brian B. Hasinoff, Krisztina L. Malisza, et al.. (1999). Mechanisms of beneficial effects of probucol in adriamycin cardiomyopathy. Molecular and Cellular Biochemistry. 196(1-2). 43–49. 24 indexed citations
16.
Iliskovic, Natasha, Brian B. Hasinoff, Krisztina L. Malisza, et al.. (1999). Mechanisms of beneficial effects of probucol in adriamycin cardiomyopathy. PubMed. 196(1-2). 43–49. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026